Prospective evaluation of innovative prototypical non-contrast MRI sequences

Not Applicable

Recruiting

• Conditions: Pancreas; Malignant neoplasm of liver and intrahepatic bile ducts; Uterus, unspecified; Malignant neoplasm of rectum; Malignant neoplasm of uterus, part unspecified; Benign neoplasm of other and ill-defined parts of digestive system; D26.9; C20; C55; D13

• Registration Number: DRKS00023805
• Lead Sponsor: Kantonsspital Baden Radiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-12-11
• Results First Posted: 2022-07-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Patients undergoing one of the following examinations:
Abdominal MRI of
- liver
- rectum
- pancreas
- female pelvis
- prostate
MRI of the breast
Informed Consent

Exclusion Criteria

- general MRI contraindications (devices (e.g. certain pacemakers), pregnancy, claustrophobia)
- severely reduced general condition
- other reasons to keep examination short
- age < 18 years
- no availability of scan time within the clinical program
- pregnancy
- loss of decision making capacity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Possible superiority or non-inferiority of non-contrast MRI sequences without use of ionizing radiation in comparison to the current clinical routine protocol<br>workflow improvements by application of innovative AI algorithms

Secondary Outcome Measures

Name	Time	Method
reduced duration of image acquistion through compressed-sensing and k-space based deep learning algorithms, cost reduction